From 01 December 2018, horses competing in the USA under USEF rules can apply for a Therapeutic Use Exemption (TUE) for pergolide after submitting proof of diagnosis. This is a great step forward for the many horses with PPID that continue to compete. See USEF Announces New Therapeutic Use Exemption (TUE) Status for Pergolide Administration Effective December 1, 2018.
The FEI continue to class pergolide as a prohibited substance - controlled medication. All members of the equestrian community are welcome to submit a suggested change to the Equine Prohibited Substances List - if you feel that the FEI should review their classification of pergolide/Prascend for horses diagnosed with PPID, complete and return the FEI Equine Prohibited Substances List submission form.
The FEI continue to class pergolide as a prohibited substance - controlled medication. All members of the equestrian community are welcome to submit a suggested change to the Equine Prohibited Substances List - if you feel that the FEI should review their classification of pergolide/Prascend for horses diagnosed with PPID, complete and return the FEI Equine Prohibited Substances List submission form.
RSS Feed